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Background: Next-generation sequencing sample preparation requires nanogram to microgram quantities of DNA;
however, many relevant samples are comprised of only a few cells. Genomic analysis of these samples requires a
whole genome amplification method that is unbiased and free of exogenous DNA contamination. To address these
challenges we have developed protocols for the production of DNA-free consumables including reagents and have
improved upon multiple displacement amplification (iMDA).
Results: A specialized ethylene oxide treatment was developed that renders free DNA and DNA present within
Gram positive bacterial cells undetectable by qPCR. To reduce DNA contamination in amplification reagents, a
combination of ion exchange chromatography, filtration, and lot testing protocols were developed. Our multiple
displacement amplification protocol employs a second strand-displacing DNA polymerase, improved buffers,
improved reaction conditions and DNA free reagents. The iMDA protocol, when used in combination with DNA-free
laboratory consumables and reagents, significantly improved efficiency and accuracy of amplification and sequencing
of specimens with moderate to low levels of DNA. The sensitivity and specificity of sequencing of amplified DNA
prepared using iMDA was compared to that of DNA obtained with two commercial whole genome amplification kits
using 10 fg (~1-2 bacterial cells worth) of bacterial genomic DNA as a template. Analysis showed >99% of the iMDA reads
mapped to the template organism whereas only 0.02% of the reads from the commercial kits mapped to the template.
To assess the ability of iMDA to achieve balanced genomic coverage, a non-stochastic amount of bacterial genomic DNA
(1 pg) was amplified and sequenced, and data obtained were compared to sequencing data obtained directly from
genomic DNA. The iMDA DNA and genomic DNA sequencing had comparable coverage 99.98% of the reference genome
at ≥1X coverage and 99.9% at ≥5X coverage while maintaining both balance and representation of the genome.
Conclusions: The iMDA protocol in combination with DNA-free laboratory consumables, significantly improved the ability
to sequence specimens with low levels of DNA. iMDA has broad utility in metagenomics, diagnostics, ancient DNA analysis,
pre-implantation embryo screening, single-cell genomics, whole genome sequencing of unculturable organisms, and
forensic applications for both human and microbial targets.
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Next-generation DNA sequencing (NGS) typically requires
nanogram to microgram levels of DNA. Many specimens
of interest have insufficient amounts of nucleic acids for
direct sequencing. To sequence these samples one must
amplify the DNA without altering the representation of the* Correspondence: Mark.eshoo@abbott.com
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unless otherwise stated.original DNA sample. A widely used method for whole
genome amplification is multiple displacement amplifica-
tion (MDA); MDA relies on priming of target DNA with
random primers and the use of the strand-displacing φ29
polymerase to amplify all of the DNA in a given sample
[1-3]. φ29 DNA polymerase is a highly processive, strand-
displacing polymerase with a very low error rate of 1 in
106-107 nucleotides [4,5]; the error rates of Taq polymerase
and Pfu polymerase, both commonly used in PCR are 3 in
104 and 3 in 106, respectively [6,7]. Recently a method forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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called MALBAC was reported to perform better than
MDA [8]. This method employs several rounds of multiple
primer annealing extension cycles with a strand-displacing
polymerase followed by PCR. Another report describes the
use of MDA in nanoliter-scale polydimethylsiloxane micro-
wells produced in a microfabrication facility [9]. Despite
total reaction volumes of 12 nl, the segregation of intact
bacterial cells does not result in total fluidic isolation, re-
quires nanoliter liquid handling capabilities and loading
cells at a density that results in 90% empty wells. In this
study, we report improvements to typical φ29-based MDA
protocols through the addition of a second strand-displacing
DNA polymerase, improved reaction formulation and condi-
tions. Previous studies have shown that φ29-based amplifica-
tion in the presence of a second strand-displacing DNA
polymerase improves DNA microarray sensitivity relative to
multiplex PCR amplification or amplification with φ29 DNA
polymerase alone [10]. Our iMDA protocol does not require
the use of FACS, specialized microfabrication or operating
with nanoliter volumes yet provides an ultraclean DNA
amplification reaction.
A number of MDA kits are commercially available; how-
ever, these kits generally recommend 10 ng of template
DNA. This requirement stems from the fact that reagents
included with the kits contain contaminating DNA that
compete with the amplification of template of interest
[11]. Sensitivity of MDA can be significantly improved by
employing reagents that are free of contaminating DNA.
In addition, laboratory consumables can also be a source
of contaminating DNA that can confound genetic ana-
lyses. Between 1993 and 2009 the “phantom of Heilbronn”
was one of Germany's most wanted criminals; this female
DNA profile was found in samples collected at over 40
crime scenes [12]. After inconsistent results led to a more
thorough investigation, the DNA profile was found to be-
long to a woman working in the factory that made swabs
used to collect DNA evidence [12]. There have also been
reports of DNA contamination in nucleic acid extraction
columns with both mouse-specific nucleic acids and xeno-
tropic murine leukemia virus-related virus (XMRV) were
detected in the eluants from new naïve columns [13,14].
These reports could be dismissed as isolated incidents ex-
cept that upon screening of public, non-primate nucleic
acid sequence databases such as NCBI, Ensembl, JGI, and
UCSC, contamination with the primate-specific element
AluY was found in 492 of 2749 database entries, suggest-
ing widespread human DNA contamination in studies
employing DNA sequencing [15].
In previous work by others, enzyme production methods
have been modified to reduce contaminating DNA [11]. In
addition, PCR amplification buffers and enzymes have been
decontaminated by treatment with heat-sensitive DNA nu-
cleases [16]. UV irradiation has also been used todecontaminate reagents and laboratory disposables used in
MDA [17] but is of limited value as the extent of the DNA
degradation by the UV light decreases with the square of
the distance from the UV light source and can have a nega-
tive effect on the properties of the reagents and mate-
rials treated. Laboratory disposables have also been
decontaminated with ethylene oxide (ETO) [18]. The ef-
fectiveness of both UV or ethylene oxide treatment has
been limited for nucleic acid decontamination as the
cell walls and membranes of an organism can serve to
protect the cellular DNA [19,20].
In this study we report the development and performance
of methods for producing ultraclean iMDA reactions that
are especially well suited for whole genome analyses by
NGS. As part of these studies we developed an ethylene
oxide protocol for the decontamination of laboratory con-
sumables that inactivates free DNA as well as dried cellular
DNA. The ultraclean reagents and consumables enabled
the amplification of trace levels of target DNA while main-
taining both genomic representation and balance of the
starting DNA sample.
Results
Decontamination of laboratory consumables with ETO
To determine the effectiveness of the ETO treatment, la-
boratory consumables were contaminated with bacterial
DNA, whole bacterial cells, or human DNA. K. pneumo-
niae DNA was dried onto pipette tips prior to the ETO
treatment protocol. Four identical sets of ten contami-
nated pipette tips were packaged into individual test
boxes. Three of these test boxes were subject to the ETO
protocol. The contaminating DNA was recovered by rins-
ing the pipette tips repeatedly with warm Tris-EDTA buf-
fer. The quantity of the DNA recovered from the pipette
tips was determined with a K. pneumonia-specific qPCR
assay. From the tips not treated with ETO, the average
amount of DNA recovered was 21 ng per tip. Of the fif-
teen tips treated with ETO, all had K. pneumonia DNA
below the limit of detection of the qPCR assay (0.350 pg)
representing a greater than 6x104 fold reduction in the
level of detectable DNA (Table 1).
To determine the effectiveness of the ETO treatment
protocol for the elimination of cellular DNA, B. cereus
overnight cultures in rich media (20-μl and 100-μl aliquots)
were dried in micro-centrifuge tubes and subject to ETO
treatment in differing locations in the treatment chamber.
The nucleic acids were recovered from the tubes, and the
level of B. cereus DNA was determined using a Bacillus-
specific qPCR assay. Between 79 ng and 101 ng of Bacillus
DNA was recovered from non-ETO-treated tubes contami-
nated with the 20-μl samples and between 290 ng and
514 ng was recovered from tubes contaminated the 100-μl
aliquots (Table 1). All ETO-treated tubes that had been
contaminated with Bacillus cells had DNA below the limits
Table 1 Decontamination of laboratory consumables with ethylene oxide treatment
DNA recovered
Contamination type No treatment (n) ETO treated (n)
Pipette tips Bacterial DNA 21 ng ± 3 (5) BLD* (15)
Microcentrifuge 20 ul Bacterial cells
Tubes 90 ng ± 11 (4) BLD* (15)
Microcentrifuge 100 ul Bacterial cells
Tubes 402 ng ± 112 (3) BLD* (2)
Extraction columns Free DNA-human 10 ng ± 2 (3) BLD* (3)
*BLD = below the limit of detection (LOD).
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a >105 fold reduction in the amount of detectable DNA
following ETO treatment. Based upon the performance of
the exogenous qPCR internal positive control there was
no indication of qPCR inhibition.
Macherey-Nagel nucleic acid extraction columns were
contaminated with 20 ng of human genomic DNA and
treated with the ETO protocol. DNA was recovered from
the columns, and the level of human DNA was determined
with human Alu-specific qPCR. There was a >12,000 fold
reduction in the DNA recovered from the ETO-treated
vs. untreated contaminated columns (Table 1). The ETO-
treated columns were also tested to assure that the ETO
treatment did not affect performance. Three treated and
three untreated columns were used to extract 100 ng of K.
pneumoniae DNA with no significant difference in per-
formance (85.4% ± 3.9% recovery with ETO-treated col-
umns vs. 90.2% ± 0.8% recovery from untreated columns).
Comparison of sensitivities of iMDA and commercial
MDA kits
The sensitivity and specificity of the iMDA protocol was
compared to sensitivity and specificity of two different
commercial MDA kits: Qiagen REPLI-g® UltraFast Mini
Kit and GenomiPhi V2 DNA Amplification Kit. For these
tests, a very low level of B. cereus bacterial genomic DNA
(10 fg, equivalent to the expected DNA from ~1-2 bacter-
ial cells) was used as a template in the amplification reac-
tions. The resulting amplified DNA was sequenced on an
Ion Torrent semiconductor sequencing system. The DNA
sequences from each reaction were subject to analysis with
the Ibis Galaxy Analysis software to determine their meta-
genomic species composition; the identified species in
each sample were used to construct the pie-charts shown
in Figure 1. The iMDA sequencing reactions produced
1.14 × 106 reads (average read length of 118 bases)
with >1.13 × 106 of the reads specifically identified by
the Ibis Galaxy analysis. The iMDA template genome,
B. cereus was identified as the source of >99.4% (B. ce-
reus specific reads/total mapped reads) of the mapped
reads with 0.2% of the reads mapping to other Bacillus
clade species.Sequencing of the Qiagen REPLI-G MDA amplified
DNA produced 4.1 x 105 total reads (average read length
of 114 bases) with 99.8% of the reads being mapped by the
Ibis Galaxy analysis. The vast majority (>96.3%) of the
reads mapped to Ralstonia pickettii, 3% mapped to E. coli
or Shigella, and only 0.02% mapped to the template gen-
ome, B. cereus. Due to the close genetic similarity of E. coli
and Shigella species, these reads were combined in
Figure 1. Sequencing of the Genomiphi V2 MDA amplified
DNA generated 1.36 x 106 total reads (average read length
of 114 bases) with 1.35 x 106 reads being mapped by the
Ibis Galaxy analysis. The majority of the reads mapped to
E. coli (76.4%) with an additional 5.8% mapping to Shigella
species. Again, because of the close genetic similarity of E.
coli and Shigella species, these reads were combined in
Figure 1. Only 0.02% mapped to the actual template, B. ce-
reus. The identification of O. cuniculus in the Genomiphi
V2 reactions was confirmed by collecting those specific
reads (27,896) and using a separate metagenomic BLAST
analysis. Further analysis showed that of the reads match-
ing O. cuniculus, 80% mapped to the alpha-globin gene.
The level of relative sensitivity of the iMDA reaction was
compared to the REPLI-G WGA and Genomiphi V2 WGA
by dividing the percentage of reads mapped to B. cereus in
iMDA (99.5%) by the percentage of reads mapped to B. ce-
reus in the commercial WGA reactions (0.02%). From this
analysis, the iMDA reaction was nearly 5000 fold more sen-
sitive than the REPLI-g WGA and the Genomiphi V2
WGA when there was a low level of input template.
Genomic representation analysis of iMDA DNA by NGS
To assess whether the iMDA method achieves relatively
complete coverage of the input genome, a non-stochastic
amount of B. cereus template DNA (1 pg) was amplified
(11,638,000 fold) in a 2-h iMDA reaction. An aliquot of
the iMDA reaction and two independent non-amplified B.
cereus genomic DNA (1 μg) samples were used to produce
sequencing libraries. The sequencing reactions were mapped
to the B. cereus ATCC 10987 (NC_003909.8) published se-
quence with NextGENe software from SoftGenetics. The re-
sults are summarized in Table 2. Sequence data obtained
from the iMDA template and from both of the genomic








Other 3% Other 1%
B. cereus 0.02%* B. cereus
0.02%*
a b c
Figure 1 Metagenomic sequence analysis of 10 fg of B. cereus genomic DNA amplified by (a) the Ibis Ultraclean iMDA protocol or with
commercial WGA Kits (b) Genomiphi V2 WGA or (c) Qiagen REPLI-g WGA. All amplified reactions were sequenced by ion semiconductor
sequencing (Ion Torrent PGM) followed by metagenomic analysis. *All reads that mapped to the B. cereus clade (i.e., B. cereus, B. thuringiensis, and
B. anthracis) are reported as B. cereus. **All reads that mapped to Escherichia or Shigella are reported as E. coli.
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ome at least 1X coverage) and greater than 99.9% of the gen-
ome with at least 5X coverage. The average read lengths
were comparable (212 to 224 bases) as were the total num-
ber of bases read (398 MB for the iMDA template vs.
574 MB for the genomic DNA). The average coverage of the
iMDA template was 64 fold, whereas that of the purified
genome was 105 fold. Figure 2 depicts the coverage vs. pos-
ition for the iMDA data at various degrees of resolution;
these data demonstrate the uniformity of the genomic cover-
age indicating that the iMDA protocol did not introduce
bias. The depth of coverage between iMDA and genomic
DNA samples were compared in 500-bp bins across the gen-
ome (Figure 3). The average variation between the two sam-
ples of genomic DNA was 1.1 fold (±1.1). The average
variation between iMDA and the genomic DNA was 1.5 fold
(±1.4); for 82.7% of the sequence bins the variation was
within 2 fold and for 99.0% of the bins variation was within
4 fold. This is especially notable as the iMDA sample was
amplified more than 1.1x107 fold. We were not able to makeTable 2 Whole genome sequence analysis of B. cereus
genomic and iMDA DNA
Genomic-1 Genomic-2 iMDA-1 pg
Total MB 445 574 398
≥ 1X coverage 99.978% 99.979% 99.975%
≥ 5X coverage 99.941% 99.939% 99.898%
Average read length 224 213 212
Average coverage 82 105 64
Total reads 1989230 2696410 1879724
Mapped reads* 1988492 2695230 1879079
B. cereus** 99.80% 99.62% 99.64%
*Mapped reads were identified with the Ibis Galaxy analysis.
**Includes all reads that mapped to the B. cereus clade, (i.e., B. cereus, B.
thuringiensis, and B. anthracis).a comparable comparison for representation and coverage
using commercial MDA kits. For example MDA utilizing
the illustra genomiphi V2 kit with 1 pg of B cereus template
DNA yielded only 37 ng of B. cereus DNA, as determined by
qPCR. The total DNA yield of 10.9 μg of DNA indicated
only 3.3x104 fold amplification of the B. cereus DNA and less
than 1% of the total amplified DNA was derived from the
template DNA.
Coverage uniformity across the genome
In order to assess coverage uniformity and relative bias
generated by the iMDA process we generated Lorenz
curves from sequence derived from 1 pg of B.cereus gen-
omic template amplified by iMDA and unamplified tem-
plate. The results are shown in Figure 4 in which we
compare the Lorenz curves from both samples at an aver-
age coverage depth of 73X. The diagonal line indicates
perfect uniformity of coverage and deviation indicates an
uneven distribution of reads. It is evident that the iMDA
provides a very high uniformity of genomic coverage and
this is in good agreement with the 99.9% coverage value
calculated in Table 2.
Discussion
Advancements in NGS technologies are revolutionizing
biology. The ability to generate very deep sequence ana-
lysis of a DNA sample in a very short time allows the in-
vestigation of many complex samples with meta-genomic
analysis. However, any contaminants contained in the
sample buffers, enzymes, or laboratory consumables will
confound the analysis. There are many potential sources
of contamination including pipette tips, tubes, extraction
columns, and commercial enzymes and buffers. Contam-
ination in any of these may negate even the most stringent
contamination controls. We demonstrate here the ability
to completely remove detectable levels of contaminating
Figure 2 Whole genome coverage of iMDA DNA. One picogram (pg) of B. cereus genomic DNA was amplified by the iMDA protocol and the
amplified DNA was sequenced. Plots show depth of coverage vs. the position in the reference genome at increasing magnifications. (a) Mapping
across the entire reference genome. (b) Mapping from 2 MB to 2.5 MB in the reference genome. (c) Mapping from 2.200 MB to 2.205 MB in the
reference genome.
Figure 3 Relative sequencing balance across the B. cereus genome. (a) Comparison of balance of two independent libraries made from 1 μg
of B. cereus genomic DNA in 500-bp bins without iMDA. (b) Comparison of balance between iMDA DNA obtained from 1 pg of B. cereus genomic
DNA template vs. 1 μg of genomic DNA across the genome in 500-bp bins.
































Cumulative fraction of genome
Figure 4 Lorenz curve iMDA and genomic sequencing of B.
cereus. Lorentz curves depict the relative bias in average read
coverage across the B. cereus genome. Each curve was calculated by
dividing the genome into 500 bp bins, counting the average read
depth across each bin, and using the resultant cumulative
distribution function for read depth to determine the cumulative
proportion of total genome coverage (y-axis) accounted for by the
cumulative proportion of bins (x-axis). The ideal Lorentz curve (black line)
for a distribution in which all of the bins have the same coverage is
plotted for comparison.
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columns with an optimized ethylene oxide treatment
process. This process did not interfere with downstream
applications.
Despite improvements in NGS sensitivity, there is still
the requirement for a significant amount of template DNA;
typically 100 ng to 5000 ng of input DNA. Many important
specimens contain DNA at levels far below this threshold.
To address this problem, a number of methods have been
developed to amplify DNA for NGS. However, these tech-
nologies are limited by the level of contaminating DNA in
enzymes, buffers, and reagents used during the amplifica-
tion and by their abilities to maintain representation of the
starting sample. In some cases individual cells have been
successfully isolated, amplified, and sequenced, but this typ-
ically required multiple rounds of fluorescence-activated
cell sorting (FACS) [21], micromanipulation [22], or micro-
fluidics [23] to separate the intact, individual cells. Although
these are powerful techniques, many samples of interest
contain free DNA and cannot be isolated in this manner.
Also, the amplification technology can introduce tre-
mendous bias in the sequencing coverage [17]. Most
NGS technologies also employ a clonal amplification
step, which can result in further bias. Commercially avail-
able MDA kits can be used to amplify DNA for NGS but
typically recommend >10 ng of initial template. Even the
recent single cell genomics studies start with ~5 pg, the
genomic DNA equivalent of a single eukaryotic cell [24].This study compared the combination of ultraclean reagents
and the iMDA protocol with two commercial MDA kits. In
this study we have developed methods for preparation of ul-
traclean reagents and have developed an improved multiple
displacement amplification protocol that enables the suc-
cessful amplification of 10 fg of DNA template – 1,000,000
fold less than required by commercial kits.
The iMDA protocol has several features that, in com-
bination, improve its performance over a standard
MDA reaction. First the iMDA reaction employs φ29
DNA polymerase and a second strand-displacing poly-
merase Klenow exo-. Though Klenow exo- is not a
proof reading polymerase it has an error rate that is
comparable to Taq [25]. The combined use of φ29 and
Klenow has been previously shown to improve amplifi-
cation compared to amplification by φ29 alone with
DNA microarrays [10]. DNA amplification by Klenow
exo- used in strand displacement amplification (SDA) is
not limited to higher molecular weight templates like
MDA using φ29 DNA polymerase [3,26]. We posit that
the use of these two strand-displacing DNA polymer-
ases may complement each other to better amplify tem-
plates of varying lengths. The iMDA reaction buffer
also contains high levels of the thermo-protectant tre-
halose, which enables the reaction to be performed at
37°C vs. 30°C. Trehalose has also been previously shown
to improve MDA performance [27]. The iMDA reaction
buffer also contains high levels of non-ionic detergent
which improved the yields of the reactions [11]. Lastly
the iMDA protocol also employs, random septamers ra-
ther than hexamers to provide a correspondingly higher
Tm and longer primer length has been shown to reduce
the Km of Klenow fragment potentially improving its per-
formance in iMDA [28]. The iMDA protocol employs a
very high fidelity proof reading DNA polymers, φ29, and a
non-proof reading polymerase with an error comparable
to Taq DNA polymerase Use of DNA amplified using the
iMDA protocol in NGS reactions resulted in greater
coverage across the genomic template than did commer-
cially available MDA kits and maintained representative
balance especially when employing processes for removing
background DNA in the reagents. Combined with ethyl-
ene oxide treatment protocol for the decontamination of
the laboratory consumables, developed in this study, the
sequencing coverage and sequencing accuracy from speci-
mens with low levels of DNA is greatly improved.
By employing this combination of strategies, the iMDA
method outperforms published MDA in the specific ampli-
fication of target template and uniformity of coverage indi-
cating very little introduction of bias even with extreme
amplification [11]. The iMDA protocol does not require ex-
tensive enzyme purification or microfabrication facilities
and enables the use of standard reaction volumes. This
combination of ultraclean consumables and reagents, along
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opportunity for specific detection and genomic sequence
analysis from samples that were previous not possible due
to template limitation.
Conclusions
The iMDA reaction developed in this study significantly
outperformed commercial MDA kits in the ability to amp-
lify specimens with low levels of DNA. and importantly the
iMDA protocol maintains balance and representation. The
iMDA protocol combined with ultra-clean reagents and
consumables has broad utility for metagenomics, molecular
diagnostics, ancient DNA analysis, pre-implantation em-
bryo screening, whole genome analysis of circulating tumor
cells, and forensic applications for both human and micro-
bial targets. Use of this protocol will make in-depth genetic
analysis of extremely low level DNA templates, including
those derived from single cells and viruses, possible.
Methods
Bacterial culture, nucleic acid preparation, and qPCR
B. cereus (ATCC 10987) was aerobically cultured in LB
liquid medium (Becton Dickenson, Franklin Lakes, NJ)
at 30°C for 18 h. The number of colony forming units
(CFU) per μl, determined by plating, was ~3,000. Aliquots
of this culture (20 μl or 100 μl) were dried in sterile, 2-ml
screw cap microcentrifuge tubes (Sarstedt, Germany). B.
cereus DNA was recovered from the tubes by adding
250 μl of 10 mM Tris, pH 7.5, 0.05 mM EDTA that had
been incubated at 50°C, vortexing for 30 seconds, and in-
cubating at 95°C for 15 min, followed by another 60 sec-
onds of vortexing. The solution was chilled on ice and
diluted 1:100 with 10 mM Tris, pH 7.5, 0.05 mM EDTA
and used directly in qPCR.
Bacterial DNA for contamination studies of the pip-
ette tips was prepared from K. pneumonia (ATCC
13883). Cells were grown overnight on nutrient agar
plates (Becton Dickenson). DNA was extracted using
the Wizard Genomic DNA Purification Kit (Promega,
Madison, WI) according to the manufacturer’s protocol.
This DNA (3 μg) was used in a 40-ml iMDA reaction
with a 6-h incubation at 37°C to yield ~40 mg of ampli-
fied DNA. The resulting amplified DNA was diluted to
10 ng/μl and used to contaminate 200-μl pipette tips
(Mettler-Toledo, Columbus, OH) by pipetting 100 μl of
the DNA solution into each tip ten times with a one
second hold during the fill step of each cycle. The solu-
tion was ejected, and the tips were allowed to dry in a
biosafety cabinet. To obtain test samples, each tip was
washed ten times with 120 μl of 50°C 10 mM Tris,
pH 7.5, 0.05 mM EDTA.
Human DNA (Promega) was used to contaminate
Nucleospin Blood Columns (Macherey-Nagel, Bethlehem,
PA). The DNA was diluted to a concentration of 1 ng/μlin 10 mM Tris, pH 7.5, 0.05 mM EDTA and 20 μl was
spotted onto the center of each of the extraction mem-
branes. The DNA was allowed to dry on the columns
overnight. To obtain test samples of DNA from the col-
umns, 75 μl of 55°C 10 mM Tris, pH 7.5, 0.05 mM EDTA
was added to the columns followed by a 15-min incuba-
tion at room temperature. Columns were centrifuged for
three minutes at 6,000 × g. The eluate was removed to a
separate tube, and the column wash step was repeated
with a 3-min, 14,000 × g recovery spin. The eluants were
combined.
All DNA stocks were quantified by organism-specific
qPCR. All qPCR reactions were performed and analyzed
on a StepOnePlus™ Real-Time PCR system (Life Tech-
nologies, Carlsbad, CA). qPCR cycling conditions for all
qPCR assays were as follows: 95°C for 10 min, 45 cycles of
denaturation 95°C for 15 s, and annealing/extension 60°C
for 1 min in a 25-μl reaction containing Brilliant II QPCR
Master Mix with High ROX (Agilent Technologies, Wood
Dale, IL), 500 nM of each primer, and 200 nM probe. All
reactions were performed in duplicate with four negative
(no template) controls (NTC) and 16 standards prepared
from dilutions of extracted OD260 quantified genomic
DNA. An internal positive control (Life Technologies) was
included to allow detection of any inhibition by the material
recovered from the ETO-treated tubes and pipette tips.
K. pneumonia DNA was quantified using the following
primers and probes: forward, AGCGCAACCCTTATCCT
TTGT; reverse, CACTGGCAGTCTCCTTTGAGTTC;
probe, FAM-CCAGCGGTTAGGCC-MGB. B. cereus DNA




TAMRA. A previously described human Alu Yd6 qPCR
protocol was used to quantitate human DNA [29]. The
limits of detection (LODs) for the DNA on tips and tubes
was0.35 pg, for K. pneumoniae DNA, 0.72 pg for cellular
B. cereus DNA and 1.0 pg for human DNA.. These values
include the extract dilution used in the qPCR assay and
the analytical LODs for all qPCR assays was 10–20 fg.
Improved multiple displacement amplifications (iMDA)
All iMDA reactions were performed in 100-μl volume and
contained 50 mM Tris, pH 7.6 (Sigma-Aldrich Corp., St.
Louis, MO), 12 mM MgCl2 (Sigma-Aldrich), 10 mM (NH4)
2SO4 (Sigma-Aldrich), 0.57 M trehalose dihydrate (HPLC
grade, Sigma-Aldrich), 1.1% V/V Tween 40 (Sigma-Al-
drich), 2.8 mM dNTP mix (Bioline, Taunton, MA), 4 mM
dithiothreitol (Life Technologies), 50 μM random septamer
with a single 3’ phosphorothioate linkage (IDT, Coralville,
IA), and 2 ng/μl sonicated polyadenylic acid (Abbott Mo-
lecular, DesPlaines, IL). After the addition of template
DNA, the reactions were incubated at 95°C for 1 min
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(Bio-Rad Laboratories, Hercules, CA). One hundred
units of φ29 DNA polymerase (100U/μl, custom formu-
lation of available stock, New England Biolabs, Ipswich,
MA) and 50 units (50U/ul) of Klenow fragment exo-
(New England Biolabs) were added, and the reactions
were incubated at 37°C for 2 h followed by a 10-min in-
cubation at 85°C. Clean production lots of amplification
enzymes were screened and identified by using 10 fg bac-
terial DNA as template and showing >90% of the sequen-
cing output using the amplified DNA was template derived.
Ultra-clean iMDA reaction buffer without DTT, dNTPs,
and primers was prepared by passing the buffer over a
Q100 anion exchange membrane (Sartorius, Bohemia, NY)
and through a 0.2-μm filter (Sartobran P 150, Sartorius) at
a flow rate of 30 mL/min with the buffer collected and
stored in a 500-mL IV bag (Metrix, Dubuque, IA) to main-
tain purity. Random septamers were dialyzed twice for
4 hours at 4°C against 4 L of solution containing 10 mM
Tris, pH 8.0, and 50 μM EDTA using a 5-mL Float-A-
Lyzer G2 with a 0.5–1 kDa MW cutoff (Spectrum Labora-
tories, Rancho Dominguez, CA); septamers were then
passed through a Ultracel 30 K spin filter (Millipore Corp.,
Billerica, MA) and added to the iMDA buffer. Ultraclean
nucleotides and 1 M DTT stocks were prepared by passing
the solutions through a Ultracel 30 K spin filter (Millipore)
before adding to the iMDA reaction mix. Individual lots of
iMDA enzymes were screened for contaminating bacterial
DNA by broad-range PCR and ESI-MS [30]. The LOD of
this amplification when combined with NGS was less than
1 fg.
Commercial MDA assays, Qiagen REPLI-G Ultrafast
WGA Reactions (Cat. no. 150033, Lot 142330089; Qiagen,
Valencia, CA) and illustra GenomiPhi V2 DNA Amplifica-
tion Kit (Cat. no. 25-6600-30, Lot 4683797; GE Healthcare
Biosciences, Piscataway, NJ) were carried out in a 20-μl re-
action volume according to manufacturers’ protocols with
a 3-h incubation time at 30°C.
Ethylene oxide treatment and materials
The consumables contaminated with bacterial or human
DNA were sealed into ETO treatment pouches (Steris,
Mentor, OH). The shrink wrap on new pipette tip boxes
was slit ~2” with a clean single-edge razor blade. The
200-μl PCR tubes and 2.0-ml microcentrifuge centrifuge
tubes were packed in plastic bottles with loose lids held
in place with lab tape. All materials were packed into
Steris-Isomedix Vis-U-All Self-Seal Pouches (STERIS).
The bags were then packaged into cardboard boxes and
shipped to Steris Isomedix for treatment. The ethylene
oxide decontamination protocol was comprised of a pre-
conditioning dwell time of >24 h at 115 °F, exposure to
ethylene oxide at 14.7 inHgA at 125 °F for 5 h, followed
by four successive nitrogen washes at 28 inHgA.Library preparation and ion semiconductor sequencing
DNA (1 μg) was fragmented by sonication using a Covaris
S2 (Covaris, Woburn, MA), and libraries were prepared ac-
cording to the Ion Plus Library Fragment Kit Protocol (Life
Technologies) for either 100 or 200 base sequencing with
5 cycles of pre-OneTouch PCR enrichment during which
the reaction was split into three tubes to minimize amplifi-
cation bias. Size selection was performed with the 2.0%
agarose Pippen Prep cassettes (Sage Scientific, Beverly,
MA). Final library quality and quantity were assessed
with the Agilent 2100 Bioanalyzer (Agilent Technologies)
followed by Ion qPCR (Life Technologies). Libraries were
amplified and enriched using the Ion OneTouch™ 100 or
200 base template kit (Life Technologies) according to the
manufacturer’s standard protocol. Enriched Ion Sphere™
particles were sequenced on the Ion Torrent Personal
Genome Machine (Life Technologies) using the Ion
PGM™ Sequencing 100 or 200 Kit (Life Technologies) and
314 or 316 chips (Life Technologies). Base calling and sub-
sequent FASTQ output was generated by the Ion Torrent
Server v3.2.1 software (Life Technologies).
Metagenomics and data analysis
The Ibis metagenomic analysis pipeline was developed from
a customized workflow based on tools in the Galaxy Project
(http://galaxyproject.org) developed by Penn State and
Emory University [31]. Prior to sequence analysis, reads of
less than 100 bases were filtered from the data sets. The
Ibis metagenomic analysis utilizes megablast (NCBI) results
of each sequenced read and a weighting system to deter-
mine which organisms may have been present in a sample.
The analysis runs megablast against a local NCBI GenBank
database for each read with the following parameters: a
word size of 16 and a maximum e-value of 1e-10. The e-
value and GI accession number are recorded for each read
matching an entry in GenBank. The GenBank tax-id for
each read was then determined based upon the GI number
and the species determined.
To determine the relative ‘uniqueness’ of each read a
weighting system was used to decrease the contribution of
sequences shared across multiple species compared to se-
quences specific to a given species. Following the weight-
ing, all the votes were tallied across all the species and
reads. The resulting tallies and percent of the total votes
for each species are reported. Due do their high levels of
homology reads that mapped to B. cereus, B. anthracis,
and B. thuringiensis were reported as B. cereus [32]. To
calculate the sequencing balance, the genome was divided
into 500-bp bins, and the average fold coverage across the
genome was determined for each data set (NextGENe,
SoftGenetics, Inc., State College, PA). The fold coverage
for each 500-bp bin was determined, and the fold coverage
in each 500-bp bin was divided by the average fold cover-
age across the genome. The log 2 ratio of the genomic to
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culated for each 500-bp bin and the ratios were then plot-
ted across the genome.
For depicting the relative bias in average read coverage
across the B. cereus genome we used a Lorez curve by div-
iding the genome into 500 bp bins, counting the average
read depth across each bin, and using the resultant cumu-
lative distribution function for read depth to determine
the cumulative proportion of total genome coverage (y-
axis) accounted for by the cumulative proportion of bins
(x-axis). The ideal Lorenz curve (black line) for a distribu-
tion in which all of the bins have the same coverage is
plotted for comparison.
Availability of supporting data
The sequencing data supporting the results of this article
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